AS20235 — MYLANP-AS
AS20235 announces 2 IPv4 prefixes covering 768 addresses and 0 IPv6 prefixes.
About this network
MYLANP-AS is operated by Mylan Pharmaceuticals Inc.
What it's used for
- The address space carries corporate infrastructure for a pharmaceutical company, evidenced by netnames NET-MYL and registrant Mylan Pharmaceuticals Inc.
- The AS announces 768 IPv4 addresses across 2 prefixes with 3 observed neighbours, indicating a small internal corporate estate rather than a transit or access network.
Notable
- Registrants align perfectly with the announcer, with both prefixes registered to Mylan Pharmaceuticals Inc.
- Mylan merged with Upjohn in November 2020 to form Viatris, a global healthcare company.
- The inventory consists of two IPv4 blocks, 204.128.4.0/23 and 204.128.2.0/24, with no IPv6 prefixes announced.
This description is AI-generated, best-effort context — not authoritative, and provided without any guarantee of accuracy.
Announced prefixes
- 204.128.2.0/24
- 204.128.4.0/23
Upstream networks
Adjacent networks
BGP / ASN / CIDR
awaiting query
enter an AS number, IP address, or organisation name above
IPv4
resolving...
IPv6
resolving...
Search Results
IPv4 Prefixes
—
IPv6 Prefixes
—
Total Prefixes
—
Unique /24s
—
⚠ SUSPICIOUS PREFIX ANNOUNCEMENTS DETECTED